GW Pharma CEO on original cannabis-derived drug

GW Pharma CEO on original cannabis-derived drug

GW Pharmaceuticals CEO Justin Gover discusses how the firm secured FDA popularity of its cannabis-derived drug and what it says in regards to the future of cannabis-derived medication.